Red Tortoise LLC Sells 368 Shares of Agilent Technologies, Inc. (NYSE:A)

Red Tortoise LLC lessened its position in shares of Agilent Technologies, Inc. (NYSE:A) by 52.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 336 shares of the medical research company’s stock after selling 368 shares during the period. Red Tortoise LLC’s holdings in Agilent Technologies were worth $45,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of A. CKW Financial Group increased its position in shares of Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after purchasing an additional 100 shares during the last quarter. Livelsberger Financial Advisory purchased a new position in Agilent Technologies in the 3rd quarter worth approximately $28,000. Ashton Thomas Securities LLC purchased a new position in Agilent Technologies in the 3rd quarter worth approximately $31,000. Fortitude Family Office LLC raised its position in shares of Agilent Technologies by 68.3% during the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after buying an additional 95 shares in the last quarter. Finally, Hanson & Doremus Investment Management lifted its holdings in shares of Agilent Technologies by 66.5% during the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after acquiring an additional 105 shares during the last quarter.

Insiders Place Their Bets

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at $5,947,800. This represents a 4.60 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Analyst Ratings Changes

A number of research firms recently commented on A. Sanford C. Bernstein reduced their target price on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research note on Tuesday, November 26th. Barclays reduced their price objective on Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a research report on Wednesday, November 27th. Bank of America dropped their target price on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research report on Friday, December 13th. JPMorgan Chase & Co. reduced their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 26th. Finally, Citigroup boosted their price objective on shares of Agilent Technologies to $165.00 and gave the stock a “buy” rating in a report on Thursday, December 19th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $143.62.

Agilent Technologies Stock Performance

Shares of NYSE:A opened at $151.75 on Monday. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. The company has a 50-day moving average price of $140.52 and a 200-day moving average price of $138.81. The company has a market cap of $43.34 billion, a price-to-earnings ratio of 34.33, a price-to-earnings-growth ratio of 3.98 and a beta of 1.06. Agilent Technologies, Inc. has a 12 month low of $124.16 and a 12 month high of $155.35.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. The business had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. Agilent Technologies’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.38 EPS. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st were given a dividend of $0.248 per share. The ex-dividend date was Tuesday, December 31st. This represents a $0.99 annualized dividend and a dividend yield of 0.65%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s payout ratio is currently 22.40%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.